Medicine and Dentistry
Activated Protein C Resistance
23%
Analysis
13%
Antibody
34%
Antibody Response
14%
Anticoagulation
17%
Antigen
21%
Antithrombotic
10%
Apixaban
17%
Assay
100%
Assessment
26%
Betrixaban
11%
Blood Clotting Factor 10a Inhibitor
10%
Blood Stasis
44%
Cell Function
10%
Cell Survival
10%
Cells
13%
Coagulation
32%
COVID-19
55%
COVID-19 Vaccination
12%
Diagnosis
22%
Direct Oral Anticoagulant
28%
Drospirenone
10%
Endothelial Cell
10%
Estetrol
16%
Heparin
22%
Humoral Immunity
13%
Immunoglobulin G
18%
In Vitro
17%
Infection
28%
Inpatient
17%
Laboratory
42%
Measurement
15%
Monitoring
15%
Neutralizing Antibody
44%
Oral Contraceptive
11%
Partial Thromboplastin Time
10%
Patient
62%
Plasma
33%
Protein
15%
Rivaroxaban
13%
Severe Acute Respiratory Syndrome Coronavirus 2
54%
Syndrome
10%
Therapeutic Procedure
13%
Thrombin
29%
Thrombocytopenia
10%
Thrombosis
17%
Tyrosine-Kinase Inhibitor
10%
Vaccine
29%
Virus
11%
Woman
22%
Pharmacology, Toxicology and Pharmaceutical Science
Activated Protein C Resistance
11%
Anticoagulant Agent
58%
Antigen
8%
Antivitamin K
31%
Apixaban
33%
Atrial Fibrillation
29%
Betrixaban
13%
Bleeding
30%
Blood Clotting Disorder
8%
Blood Clotting Factor 10a Inhibitor
26%
Chronic Myeloid Leukemia
18%
Clotting Time
14%
Coronavirinae
11%
Dabigatran
49%
Dabigatran Etexilate
31%
Daboia russellii
16%
Dasatinib
13%
Direct Oral Anticoagulant
84%
Diseases
13%
Drug
19%
Drug Interaction
7%
Edoxaban
15%
Emergency
16%
Ensure
8%
Estetrol
10%
Heart Infarction
7%
Heparin
34%
Idarucizumab
7%
Inflammation
8%
Low Molecular Weight Heparin
17%
Nilotinib
14%
Pharmacodynamics
10%
Pharmacokinetics
10%
Ponatinib
15%
Prospective Study
10%
Protein Tyrosine Kinase Inhibitor
27%
Prothrombin
22%
Reagent
19%
Rivaroxaban
55%
SARS Coronavirus
11%
Survival
11%
Thrombin
30%
Thrombin Inhibitor
20%
Thromboembolism
19%
Thromboplastin
26%
Thrombosis
9%
Toxic Injury
8%
Venous Thromboembolism
9%
Viper Venom
16%
Warfarin
16%
Biochemistry, Genetics and Molecular Biology
Activated Protein C Resistance
11%
All Cause Mortality
5%
Antibody
21%
Anticoagulation
15%
Antithrombin
10%
Association
5%
Blood Level
23%
Cell Function
5%
Cell Survival
5%
Coagulation
49%
Coronavirinae
8%
D-Dimer
16%
Dose
9%
Electric Potential
6%
Fibrinogen
8%
Fibrinolysis
7%
Hemostasis
32%
Heparin
17%
Histone
5%
Immunoglobulin G
7%
Immunoglobulin G
5%
Immunoglobulin M
10%
Kinetics
10%
Laboratory Technique
5%
Laboratory Test
7%
Molecular Array
5%
Myeloid
6%
Neutralizing Antibody
5%
Nucleosome
10%
Overall Survival
6%
Partial Thromboplastin Time
22%
Ponatinib
6%
Posttranslational Modification
5%
Protein S
5%
Prothrombin Time
19%
Quantitative Technique
5%
Recognition
5%
Relapse
5%
Reverse Transcription Polymerase Chain Reaction
9%
Rivaroxaban
15%
Sample
44%
SARS Coronavirus
37%
Tandem Mass Spectrometry
5%
Taxonomy
16%
Thrombin
54%
Thrombin Time
11%
Time
23%
Tyrosine Kinase Inhibitor
10%
Viperinae
6%
Virus Load
8%